Search Results 1151-1160 of 17668 for prednisone

1. Dendritic Cell Therapy After Cryosurgery in Combination With Pembrolizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Remove by Surgery - Mayo Clinic

   Patients on chronic corticosteroids for adrenal insufficiency or other reasons may enroll if they receive less than 10 mg/day of prednisone (or equivalent).

2. Clinical Trials - FT576 in Subjects With Multiple Myeloma

   study enrollment. Currently receiving or likely to require immunosuppressive therapy (e.g., prednisone > 5 mg daily) for any reason during the treatment ...

3. Fatigue Causes - Mayo Clinic

   Prednisone withdrawal: Why taper down slowly? Premenstrual dysphoric disorder · Premenstrual syndrome (PMS) · Prescription sleeping pills: What's right for you ...

4. Study Of The Bria-IMT Regimen And CPI Vs Physicians' Choice In Advanced Metastatic Breast Cancer. (BRIA-ABC) - Mayo Clinic

   Have a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (doses exceeding 10 mg daily of prednisone equivalent) or any other ...

5. Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (SA-AKI) - Mayo Clinic

   ... prednisone/prednisolone 0.5 mg/kg/day, including solid organ transplant patients. Patients with septic shock treated with corticosteroids (as per the ...

6. A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1) - Mayo Clinic

   - Are receiving systemic steroid > 10 mg of prednisone daily or equivalent or any other immunosuppressive medication at any dose level. Local steroid ...

7. A Study of MT-0169 in Participants With Relapsed or Refractory Multiple Myeloma or non-Hodgkin Lymphoma - Mayo Clinic

   Patients with a chronic condition requiring the use of systemic corticosteroids at a dose of > 10 milligram per day (mg/day) of prednisone or equivalent.

8. A Study to Evaluate the Effectiveness and Safety of Oral OPS-2071 in Subjects With Crohn's Disease Showing Symptoms of Active Inflammation - Mayo Clinic

   Use of prednisone or prednisolone > 30 mg/day or budesonide > 9 mg/day within 4 weeks prior to screening; or intravenous steroids within 4 weeks prior to ...

9. Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) - Mayo Clinic

   Treatment with prednisone > 30 mg/day for > 28 days immediately prior to study entry; Initiation or dose increase of the maintenance immunosuppressive agent ...

10. Testing Teclistamab (TECVAYLI) In Combination With Iberdomide For Hard-to-Treat Multiple Myeloma - Mayo Clinic

    ... prednisone or equivalent. Use of immunosuppressive medications for the management of iberdomide-related adverse events (AEs) or in subjects with contrast ...